Scientific research is becoming more inclusive, but one area that’s still lacking this diversity is pre-clinical research. Without knowing how medications will react to different ancestries and skin tones, millions of people are being put at risk. Our experts discuss the effect melanin has on a drug’s efficacy and changes the industry can implement right now that will make a big difference.
Guest Information:
- Sophie Zaaijer, Molecular Biologist, Consultant for Diversity, Equity, and Inclusion and Clinical Trials
- Simon Groen, Assistant Professor of Evolutionary Systems Biology, University of California at Riverside
Leave a Reply